I’ve been thinking a lot about Global Blood Therapeutics (GBT) lately and questioning my stance on voxelotor as well as my positioning. In doing so, I tried to eliminate bias the best way I can and ...

Shares of Global Blood Therapeutics (GBT) fell last week after the company reported additional results from the HOPE KIDS phase 2a trial of voxelotor in adolescent sickle cell disease patients. The ...

GBT Technologies Inc. is engaged in the development of Internet of Things (IoT), Artificial Intelligence (AI) enabled networking and tracking technologies, including wireless mesh network technology ...

BMTC Group Inc. ( ($TSE:GBT) ) has provided an announcement. BMTC Group Inc. reported a revenue increase of 5.4% for the nine months ended October ...